News

Lymphoma Hub
lymphomahub.com > medical-information > resmain-resminostat-maintenance-in-advanced-stage-mycosis-fungoides-or-sezary-syndrome

RESMAIN: Resminostat maintenance in advanced-stage mycosis fungoides or Sézary syndrome

6+ hour, 41+ min ago  (308+ words) All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional. If you are a patient or carer, please visit…...

Lymphoma Hub
lymphomahub.com > medical-information > direct-prognostic-value-of-pv-supported-ctdna-mrd-in-lbcl

DIRECT: Prognostic value of PV-supported ctDNA MRD in LBCL

2+ week, 5+ day ago  (267+ words) All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit…...

Lymphoma Hub
lymphomahub.com > medical-information > go29781-phase-iii-subgroup-analysis-mosunetuzumab-in-older-patients-with-rr-b-nhl

GO29781 phase I/II subgroup analysis: Mosunetuzumab in older patients with R/R B-NHL

3+ week, 1+ day ago  (325+ words) All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit…...

Lymphoma Hub
lymphomahub.com > medical-information > swog-s1826-3-year-follow-up-n-avd-vs-bv-avd-in-adolescents-with-as-chl

SWOG S1826 3-year follow-up: N-AVD vs BV-AVD in adolescents with AS cHL

1+ mon, 9+ hour ago  (330+ words) All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit…...

Lymphoma Hub
lymphomahub.com > medical-information > sequoia-arms-a-and-b-6-year-follow-up-results-from-ash-2025

SEQUOIA arms A and B: 6-year follow-up results from ASH 2025

1+ mon, 1+ day ago  (341+ words) All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit…...

Lymphoma Hub
lymphomahub.com > medical-information > 5-year-follow-up-mosunetuzumab-in-patients-with-heavily-pretreated-rr-fl

5-year follow-up: Mosunetuzumab in patients with heavily pretreated R/R FL

1+ mon, 2+ week ago  (320+ words) All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit…...

Lymphoma Hub
lymphomahub.com > medical-information > pirtobrutinib-approved-by-health-canada-for-the-treatment-of-rr-mcl-and-cllsll

Pirtobrutinib approved by Health Canada for the treatment of R/R MCL and CLL/SLL

1+ mon, 2+ week ago  (258+ words) All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit…...